News about Biotechnology, Pharmaceutical and Healthcare

03:50 EST 22nd November 2014 | BioPortfolio

Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors. 

Showing News Articles 1–25 of 9,700+

Friday 21st November 2014

Innovenn Commences Production of Labskin at New State of the Art Facilities

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that its innovation division, Innovenn,...

GSK führt im Index „Zugang zu Medizin“

Zum vierten Mal in Folge führt GSK den am 17. November 2014 veröffentlichten „Access to Medicine“-Index an. Der Index ist eine unabhängige Bewertung des Engagements der Top-20-Pharmafirmen zur Verbesserung des Zugangs zu Arzneimitteln und medi...

NIH research featured in National Geographic Channel documentary on sleep

The documentary, Sleepless in America, premieres on the National Geographic Channel on Sunday, November 30th at 8 p.m. ET/PT.

FEBiotec launches Symbiotica online biotech training and dissemination platform

The initiative is part of the FEBiotec Divulga project geared towards 16 and 17 year olds

Debating urban mobility and its impact on the environment and health

B·Debate, the CCCB, ISGlobal and CREAL are kicking off this series of conferences on the effects of urban growth on the environment and human health

ABPI: NHS must change to allow stratified drugs

The development of stratified medicines – especially in therapy areas outside of oncology – will have a significant effect on the NHS, according to a new report which highlights both opportunities and difficulties. The ABPI, which represents most of the major pharma companies operating in the UK, says its research shows that 90% of clinicians and other health professionals expect non-cancer st...

Genesis 2014 conference offers discounts to foreign companies

The event will take place in London on 9 December

Rob Surgical Systems begins validation of Bitrack System surgical robot

The process will take place at the Specific Pig facilities in El Prat de Llobregat

Plague – Madagascar

On 4 November 2014, WHO was notified by the Ministry of Health of Madagascar of an outbreak of plague. The first case, a male from Soamahatamana village in the district of Tsiroanomandidy, was identified on 31 August. The patient died on 3 September. As of 16 November, a total of 119 cases of plague have been confirmed, including 40 deaths. Only 2% of reported cases are of the pneumonic form.

Extrapolation of indications in biosimilars: filgrastim

Extrapolation* of indications for biosimilars is a contentious issue and has been met with concern by physicians. Members of the European Medicines Agency (EMA)’s Biosimilar Medicinal Products Working Party (BMWP) address these concerns using extra...

More discussion over WHO biological qualifier

The World Health Organization recently held its 59th Consultation on International Nonproprietary Names (INN) for Pharmaceutical Substances. At the meeting the issue of naming of biologicals including biosimilars was once again discussed.

Chinese guidelines for biosimilars

Last update:  21 November 2014Since 2003, the China Food and Drug Administration (CFDA) (simplified Chinese: 国家食品药品监督管理局) is the Chinese authority that oversees all drug manufacturing, trade, and registration.

Future bleak for Novartis' myeloma drug

Novartis suffered a major disappointment with the negative FDA panel vote for multiple myeloma candidate Farydak earlier this month, but further testing could resurrect the drug, says an analyst. The FDA's Oncologic Drugs Advisory Committee (ODAC) voted 5-2 against approval of Farydak (panobinostat) - a pan-deacetylase (pan-DAC) inhibitor - as a combination therapy with Takeda's Velcade (bortezomi...

EMA criticized for redaction of AbbVie’s data

The European Medicines Agency (EMA) has once again come under fire for the way it is implementing new European transparency rules for pharmaceuticals. The latest criticism of EMA concerns the way the agency is redacting clinical trials data.

Growth in Netherlands pharma market held back by generics policies

The pharmaceutical market in The Netherlands will rise slowly from approximately US$6.7 billion in 2014 to US$7.2 billion by 2020. Growth is being restricted by the government’s focus on generics as a cost-containment tool, according to research an...

Amgen launches biosimilars info app

Biologicals major Amgen has launched an app which aims to provide a source of information about biosimilars.

Worldwide action needed to address hidden crisis of violence against women and girls

Current efforts to prevent violence against women and girls are inadequate, according to a new Series published in The Lancet. Estimates suggest that globally, 1 in 3 women has experienced either physical or sexual violence from their partner, and that 7% of women will experience sexual assault by a non-partner at some point in their lives. Yet, despite increased global attention to violence pe...

Investigation into huge price increases for generics in the US

Two US Congressmen have sent letters to 14 drug manufacturers, including several major Indian firms, requesting information about the escalating prices they have been charging for generics.

Cipla petitions Indian Government to revoke Onbrez patents

India-based generics maker Cipla has asked the Indian Government to revoke five patents held by Swiss firm Novartis for its respiratory drug Onbrez (indacaterol), after launching its own generic version of the drug.

£30 million research boost for UK

The UK government has announced more than £30 million of new funding to develop treatments – at the same time as it launches a separate review into how to get innovative medicines to patients more quickly. Innovate UK and the Medical Research Council (MRC) are putting up the new money to fund 29 companies in rounds five and six of the BioMedical Catalyst (BMC), a pool which was established as...

Micro Droplet Systems Provide Seamless Production of Monodispersed Droplets

Dolomite Microfluidics, a sister company to flow chemistry specialist Syrris, has developed an innovative range of Micro Droplet Systems for automatic, seamless production of monodispersed droplets. Built around Dolomite’s pulseless pressure pumps, connectors and chips, Micro Droplet Systems benefit a wide range of applications, including compartmentalized chemistry, high throughput experime...

New alpha+ Pipettes

For unsurpassed pipetting accuracy at a very affordable price you can’t beat the new alpha+ pipettes from Alpha Laboratories (Eastleigh, UK). With an attractive modern design these lightweight, easy-to-use pipettes are robust and reliable even in the most challenging environments. The range includes variable and fixed volume single channel, plus 8- and 12-channel mo...

Blood-Derived Products for Personalised Medicine Research

AMSBIO is a leading international supplier of high quality human blood-derived products including whole blood, serum, plasma, buffy coat and peripheral blood mononuclear cells (PBMC).  Blood products from AMSBIO are available in a large variety of formats from a broad spectrum of healthy donors, delivered from inventory or collected to order. Working directly with donors AMSBIO is also able t...

E-Learning: Bioreactors Made Easy!

The new Bioreactor Cultivation Video Guide from INFORS HT illustrates the operational steps using the Minifors and Labfors bench-top bioreactors as examples. The video instructions allow students and newcomers to fermentation to run laboratory experiments on their own. These instructions were compiled in co-operation with the University of Applied Sciences, Esslingen, (Germany) and are now avai...

Horizon Discovery Group Launches Collection of Highly Characterized Patient-Derived Xenograft Models of Breast Cancer under SAGE Labs Brand

Largest available collection of PDX cell lines, faithfully modelling human breast cancers Horizon Discovery Group plc (Horizon), a leading provider of products, services and technologies in the field of genome engineering, today announced the launch of its Patient-Derived Xenograft (PDX) models of breast cancer under its SAGE Labs brand. The new panel is the largest available collection of highly ...


Search BioPortfolio:
Loading
Advertisement
Advertisement